Superiority of deucravacitinib was demonstrated on both co-primary endpoints and multiple key secondary endpoints in the POETYK PSO-1 trial The overall safety profile of deucravacitinib in this study ...

PRINCETON, N.J.-- (BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) today announced the pivotal study of lisocabtagene maraleucel (liso-cel) an investigational CD19-directed CAR T-cell ...

Despite their early superiority over bare-metal stents, drug-eluting stents were associated with similar event rates and survival in the latter half of follow-up in the EXAMINATION trial, which ...

Ultimovacs has clawed back confidence in its cancer vaccine candidate. Having missed the primary goal earlier this year, the Norwegian biotech has hit back with data showing that adding its vaccine to ...

SAND SPRINGS, OK, UNITED STATES, April 8, 2024 /EINPresswire.com/ -- OGI Process Equipment, a Sand Springs, Oklahoma, leading provider of industrial product solutions ...